165 related articles for article (PubMed ID: 3021382)
1. The pharmacology of agents used in the treatment of pulmonary mycoses.
Borgers M; Vanden Bossche H; Cauwenbergh G
Clin Chest Med; 1986 Sep; 7(3):439-52. PubMed ID: 3021382
[TBL] [Abstract][Full Text] [Related]
2. [Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
Mary C; Goudard M; Blancard A; Quilici M; Regli P
Ann Biol Clin (Paris); 1989; 47(9):546-9. PubMed ID: 2558599
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the treatment of systemic fungal infections.
Walsh TJ
Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of pulmonary mycoses].
Schaberg T; Lode H
Dtsch Med Wochenschr; 1992 Nov; 117(45):1725-9. PubMed ID: 1330477
[No Abstract] [Full Text] [Related]
5. [Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
Högl F; Raab W
Mykosen; 1981 May; 24(5):261-74. PubMed ID: 6265772
[No Abstract] [Full Text] [Related]
6. Cyclosporine interactions with miconazole and other azole-antimycotics: a case report and review of the literature.
Horton CM; Freeman CD; Nolan PE; Copeland JG
J Heart Lung Transplant; 1992; 11(6):1127-32. PubMed ID: 1457436
[TBL] [Abstract][Full Text] [Related]
7. In vitro antifungal susceptibility of fungi isolated from respiratory tract of patients and other sources.
Chaturvedi VP; Chaturvedi S; Khan ZU; Randhawa HS
Indian J Chest Dis Allied Sci; 1988; 30(1):36-40. PubMed ID: 3169869
[No Abstract] [Full Text] [Related]
8. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
Odds FC; Cockayne A; Hayward J; Abbott AB
J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology and pharmacokinetics of traditional systemic antifungal agents.
Barriere SL
Pharmacotherapy; 1990; 10(6 ( Pt 3)):134S-140S. PubMed ID: 2075111
[No Abstract] [Full Text] [Related]
10. Drugs for treatment of fungal infections.
Med Lett Drugs Ther; 1992 Feb; 34(864):14-6. PubMed ID: 1310518
[No Abstract] [Full Text] [Related]
11. Clinical use of systemic antifungal agents.
Benson JM; Nahata MC
Clin Pharm; 1988 Jun; 7(6):424-38. PubMed ID: 3042267
[TBL] [Abstract][Full Text] [Related]
12. [In vitro susceptibility of Cryptococcus strains to 5 antifungal drugs].
Bava AJ; Negroni R
Rev Inst Med Trop Sao Paulo; 1989; 31(5):346-50. PubMed ID: 2560840
[TBL] [Abstract][Full Text] [Related]
13. Anti-Candida drugs--the biochemical basis for their activity.
Vanden Bossche H; Willemsens G; Marichal P
Crit Rev Microbiol; 1987; 15(1):57-72. PubMed ID: 3319421
[TBL] [Abstract][Full Text] [Related]
14. [Itraconazole in the treatment of deep mycoses].
Viviani MA; Tortorano AM
Ann Ist Super Sanita; 1987; 23(4):873-7. PubMed ID: 2837939
[No Abstract] [Full Text] [Related]
15. Management of systemic fungal infections: alternatives to itraconazole.
Herbrecht R; Nivoix Y; Fohrer C; Natarajan-Amé S; Letscher-Bru V
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i39-i48. PubMed ID: 16120633
[TBL] [Abstract][Full Text] [Related]
16. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
Odds FC
Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
[TBL] [Abstract][Full Text] [Related]
17. Fungal infections and their management.
Graybill JR; Sharkey PK
Br J Clin Pract Suppl; 1990 Sep; 71():23-31. PubMed ID: 1965416
[TBL] [Abstract][Full Text] [Related]
18. In-vitro evaluation of antifungal agents in the treatment of yeast peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD).
Edwards R; Birrell LN; Finch RG
Chemioterapia; 1987 Feb; 6(1):3-7. PubMed ID: 3829134
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy of aspergillus lung disease].
Scholer HJ
Mykosen; 1983 Apr; 26(4):173-96. PubMed ID: 6306462
[No Abstract] [Full Text] [Related]
20. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
Gudewicz TM; Mader JT; Davis CP
Aviat Space Environ Med; 1987 Jul; 58(7):673-8. PubMed ID: 3304267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
